n exploratory trial of a WT1-W10 immunotherapy against pancreatic cancer in combination with the standard S1 chemotherapy.
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2018
At a glance
- Drugs WT1-W10 peptide vaccine (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 09 Feb 2018 Status changed from suspended to completed.
- 10 Feb 2017 New trial record